Trials / Completed
CompletedNCT00412451
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical Posterior Vitreous Detachment (PVD) Induction for Treatment of DME.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- ThromboGenics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter study to compare multiple doses of intravitreal microplasmin for non-surgical PVD induction for treatment of patients with DME.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ocriplasmin | Intravitreal injection, single administration |
| OTHER | Sham injection | Sham intravitreal injection |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2010-01-01
- Completion
- 2010-03-01
- First posted
- 2006-12-18
- Last updated
- 2014-12-17
- Results posted
- 2013-09-13
Locations
15 sites across 6 countries: Belgium, Germany, Italy, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00412451. Inclusion in this directory is not an endorsement.